Internal Medicine, Pulmonary Disease · Dayton, OH
NPI
1609954940
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9001 N Main St, A
Dayton, OH, 45415
Phone (937) 832-0990
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
3,428 services
Medicare patients, 2024
1,124
Average age 73
Drug cost, 2024
$5.5M
6,326 prescriptions
Company payments, 2025
$7,076
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick F Allan was code 99213 (office e&m - established), 991 times for 659 patients. In total Patrick F Allan billed 3,428 services in 40 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 991 | 659 | $63.99 | $63K |
| 99214 Office E&M - Established | Office | 418 | 256 | $91.05 | $38K |
| 99291 Critical Care E&M | Facility | 222 | 84 | $166.99 | $37K |
| 99233 Hospital E&M - Subsequent | Facility | 182 | 103 | $92.81 | $17K |
| 99204 Office E&M - New | Office | 180 | 180 | $117.06 | $21K |
| 94664 E&M - Miscellaneous | Office | 174 | 173 | $13.34 | $2,321 |
| 94060 Pulmonary Function Testing | Office | 173 | 172 | $28.78 | $4,979 |
| 94729 Pulmonary Function Testing | Office | 166 | 165 | $40.02 | $6,644 |
| 94726 Pulmonary Function Testing | Office | 158 | 157 | $39.96 | $6,313 |
| 94618 Pulmonary Function Testing | Office | 152 | 151 | $25.43 | $3,865 |
| 99232 Hospital E&M - Subsequent | Facility | 114 | 74 | $62.80 | $7,160 |
| 99212 Office E&M - Established | Office | 103 | 96 | $40.72 | $4,194 |
| 99203 Office E&M - New | Office | 62 | 62 | $62.62 | $3,882 |
| 31624 Bronchoscopy | Facility | 49 | 45 | $52.04 | $2,550 |
| 76604 Ultrasound - Nonspecific | Office | 41 | 18 | $40.91 | $1,677 |
By year: 2022 $239K for 3,708 services; 2023 $253K for 3,576 services; 2024 $244K for 3,428 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick F Allan prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,162 prescriptions and refills. In total Patrick F Allan wrote 6,326 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,162 | 1,853 | 323 | $1.2M |
| Azithromycin Generic | 990 | 1,142 | 268 | $14K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 702 | 1,021 | 246 | $21K |
| Prednisone Generic | 429 | 465 | 214 | $813 |
| Montelukast Sodium Generic | 396 | 906 | 131 | $3,032 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 256 | 412 | 93 | $257K |
| Spiriva Respimat Tiotropium Bromide | 168 | 284 | 46 | $146K |
| Bupropion Hcl Sr Bupropion Hcl | 139 | 177 | 58 | $2,482 |
| Breo Ellipta Fluticasone/Vilanterol | 129 | 201 | 35 | $79K |
| Pregabalin Generic | 126 | 146 | 25 | $1,777 |
| Ofev Nintedanib Esylate | 118 | 118 | 22 | $1.5M |
| Pirfenidone Generic | 115 | 117 | 20 | $224K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 113 | 113 | 96 | $638 |
| Dupixent Pen Dupilumab | 104 | 104 | 19 | $390K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 81 | 81 | Under 11 | $959K |
Brand drugs: - claims; generic drugs: 3,279 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick F Allan $7,076 ($7,076 in general payments such as food, travel and fees) from 18 companies. The largest payer was Intuitive Surgical, Inc. with $5,917.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 6 | $5,917 |
| GlaxoSmithKline, LLC. GSK | 32 | $341 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $128 |
| Lilly USA, LLC LLY | 2 | $110 |
| Genzyme Corporation SNY | 3 | $88.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80.32 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $72.67 |
| Grifols USA, LLC | 3 | $68.77 |
| Amgen Inc. AMGN | 2 | $39.32 |
| Baxter Healthcare BAX | 1 | $35.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.